Winton Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $108K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $151K | Sell |
|
|||||
|
2022
Q4 | $187K | Buy |
|
|||||
|
2022
Q3 | $244K | Sell |
|
|||||
|
2022
Q2 | $265K | Buy |
|
|||||
|
2022
Q1 | $335K | Buy |
|
|||||
|
2021
Q4 | $380K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $541K | Sell |
|
|||||
|
2020
Q3 | $1.27M | Buy |
|
|||||
|
2020
Q2 | $338K | Sell |
|
|||||
|
2020
Q1 | $507K | Buy |
|